Education
About Us
Working with TipRanks
Follow Us
Santen Pharmaceutical Co Ltd (SNPHF)
OTHER OTC:SNPHF
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 300.00B | ¥ 301.96B | ¥ 279.04B | ¥ 266.26B | ¥ 249.60B |
| Gross Profit | ¥ 163.21B | ¥ 163.88B | ¥ 156.57B | ¥ 146.85B | ¥ 140.73B |
| Operating Income | ¥ 56.23B | ¥ 51.90B | ¥ 32.02B | ¥ 35.98B | ¥ 37.07B |
| EBITDA | ¥ 74.18B | ¥ 70.08B | ¥ 49.26B | ¥ 53.03B | ¥ 54.99B |
| Net Income | ¥ 36.26B | ¥ 26.64B | ¥ -14.95B | ¥ 27.22B | ¥ 9.31B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 93.00B | ¥ 94.58B | ¥ 57.90B | ¥ 83.01B | ¥ 62.89B |
| Total Assets | ¥ 409.28B | ¥ 435.70B | ¥ 421.18B | ¥ 459.98B | ¥ 405.29B |
| Total Debt | ¥ 33.95B | ¥ 35.16B | ¥ 35.96B | ¥ 22.00B | ¥ 10.15B |
| Net Debt | ¥ -59.04B | ¥ -59.42B | ¥ -21.94B | ¥ -61.02B | ¥ -52.74B |
| Total Liabilities | ¥ 124.10B | ¥ 130.33B | ¥ 127.88B | ¥ 123.13B | ¥ 95.64B |
| Stockholders' Equity | ¥ 286.24B | ¥ 306.05B | ¥ 293.98B | ¥ 337.49B | ¥ 310.18B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 54.27B | ¥ 63.33B | ¥ 19.87B | ¥ 28.70B | ¥ 34.67B |
| Operating Cash Flow | ¥ 60.93B | ¥ 72.65B | ¥ 37.15B | ¥ 46.04B | ¥ 38.81B |
| Investing Cash Flow | ¥ -8.22B | ¥ -6.14B | ¥ -26.78B | ¥ -35.17B | ¥ -53.35B |
| Financing Cash Flow | ¥ -53.31B | ¥ -34.03B | ¥ -37.22B | ¥ 5.56B | ¥ -16.68B |